Skip to content
  • Sunday, 26 July 2026
  • 3:04 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies
Neuroscience & Brain Research

Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies

Rifan Muazin Jul 17, 2026 0

New research conducted by neuroscientists at the Fralin Biomedical Research Institute at VTC has fundamentally questioned a decades-old paradigm regarding…

Read More
Neuroscience & Brain Research

Virginia Tech Research Challenges Long Standing Assumptions in Cerebellar Movement Disorder Studies

Rifan Muazin Jul 2, 2026 0

New research emerging from the Fralin Biomedical Research Institute at VTC is fundamentally questioning the established framework used to study…

Read More
Advanced Materials Science

Tokyo Metropolitan University Researchers Solve Long-Standing Mystery of Foam Drainage Mechanisms Through Yield Stress Analysis

Nila Kartika Wati Apr 5, 2026 0

The fundamental physics governing how liquid drains from foams has remained a persistent enigma in soft matter science for decades,…

Read More
Advanced Materials Science

Tokyo Metropolitan University Researchers Resolve Long Standing Foam Drainage Mystery Through Bubble Dynamics Study

Nila Kartika Wati Mar 24, 2026 0

The common household experience of watching liquid seep out of a freshly sprayed cleaning foam or the head of a…

Read More
The Origin and Evolutionary Odyssey of Yeast Centromeres: A "Proto-Point" Discovery Rewrites Our Understanding of Chromosomal ArchitectureGerman Researchers Identify CD99L2 Gene as Key Driver of X-linked Spastic AtaxiaUnveiling the Microscopic Thermometer: Scientists Capture First Detailed Images of the Body’s Cold Sensor at WorkIndiana University Researchers Identify IDOL Enzyme as Novel Therapeutic Target for Alzheimer’s Disease Treatment and Neuroprotection
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ